Biotin-Linked Polyclonal Antibody to BH3 Interacting Domain Death Agonist (Bid) is a premium-quality life science research product supplied by Torvigen for laboratory and scientific applications.
Western blotting: 0.2-2µg/mL;1:250-2500 Immunohistochemistry: 5-20µg/mL;1:25-100 Immunocytochemistry: 5-20µg/mL;1:25-100 Optimal working dilutions must be determined by end user.
